EMA Met Performance Targets, Saw Increase in Inspection Requests in First Half of 2016

The EMA completed all inspections and scientific advice procedures on time and met its performance targets in the first half of 2016 even as GMP inspection requests and orphan designation applications rose, according to a newly released report.
Source: Drug Industry Daily